<DOC>
	<DOCNO>NCT01650740</DOCNO>
	<brief_summary>In recent year , grow evidence antidepressant marginally effective compare placebo mild moderate depression . In word , although many people improve take antidepressant medication , almost many get good placebo pill . One possible solution problem would give patient trail placebo prior give antidepressant , however ethical issue deceptively . New evidence placebo-responsive disorder irritable bowel syndrome show people may benefit placebos even know take . This study aim determine whether give placebo without deception people major depressive disorder follow option switch antidepressant effective strategy . There 3 group subject . The first group standard treatment arm receive duloxetine , antidepressant . The second give placebo option switch duloxetine improve . The third group receive supportive clinical visit option switch duloxetine improve . This design allow u determine whether sequenced treatment placebo without deception option switch antidepressant viable strategy . It also help u determine degree benefit come ritual receive take placebo tablet versus benefit visit doctor alone . The primary hypothesis le 5 % difference response rate 12 week sequence placebo-then-antidepressant treatment group ( subject remain placebo well switch antidepressant consider one group ) compare immediate antidepressant therapy group .</brief_summary>
	<brief_title>Study Placebo Without Deception Versus Standard Antidepressant Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Provision write informed consent Diagnosis major depressive disorder , currently depress determine DSMIV diagnostic criterion ( confirm use MINI ) Both females male , age 18 65 year Outpatient status Female patient childbearing potential must negative urine human chorionic gonadotropin ( hCG ) test enrolment must take willing take acceptable form birth control course study plan sexually active A grade 8 English comprehension , ability understand comply requirement study capable providing inform consent 17item Hamilton Depression Rating Scale ( HAMD ) score 1422 screen baseline Diagnosis past hypomanic , manic mixed state . Current past psychotic symptom Substance alcohol dependence enrolment ( except dependence full remission , except caffeine nicotine dependence ) , define DSMIV criterion Opiates , amphetamine , barbiturate , cocaine , cannabis , hallucinogen abuse DSMIV criterion within 4 week prior enrolment Any pervasive developmental disorder ( accord DSMIV criterion ) Diagnosis dementia ( accord DSMIV criterion ) Is significant risk suicide , define score ≥ 2 suicide item MADRS , suicidal ideation intent plan within 3 month prior study entry opinion investigator . Any history lifetime suicide attempt Current treatment antidepressant medication Treatment antipsychotic , mood stabilizer psychoactive medication within period 5 halflives medication prior baseline visit Known intolerance , hypersensitivity lack response duloxetine judge investigator A history treatment resistant depression ( define 2 fail lifetime trial antidepressant medication judge investigator ) Currently undergo psychotherapy initiate within past 3 month Significant medical condition would contraindicate use duloxetine untreated would need urgent attention ( determined treat physician ) Medical condition would significantly affect absorption , distribution , metabolism , excretion duloxetine Unstable inadequately treat medical illness ( e.g . congestive heart failure , angina pectoris , hypertension ) judge investigator Any clinically significant deviation reference range clinical laboratory test result judge investigator Pregnancy ( female childbearing age use adequate contraception ) lactation A positive βhCG test enrolment Involvement planning conduct study Previous enrolment randomisation treatment present study Participation another drug trial within 4 week prior enrolment study long accordance local requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>